Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546781 - 546800 out of 553685 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AE01) fingolimod (adm: O) | GILENYA 0.5MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | NovartisPharmaceuticalsCorporation |
| USA | (L04AE01) fingolimod (adm: O) | GILENYA 0.5MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | NovartisPharmaceuticalsCorporation |
| USA | (L04AE01) fingolimod (adm: O) | TASCENSO ODT 0.25MG TAB,ORAL DISINTEGRATING | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CyclePharmaceuticals,Ltd. |
| USA | (L04AE01) fingolimod (adm: O) | TASCENSO ODT 0.25MG TAB,ORAL DISINTEGRATING | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CyclePharmaceuticals,Ltd. |
| USA | (L04AE01) fingolimod (adm: O) | TASCENSO ODT 0.5MG TAB,ORAL DISINTEGRATING | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CyclePharmaceuticals,Ltd. |
| USA | (L04AE01) fingolimod (adm: O) | TASCENSO ODT 0.5MG TAB,ORAL DISINTEGRATING | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CyclePharmaceuticals,Ltd. |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA STARTER PACK 7 DAY | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA STARTER PACK 7 DAY | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA STARTER KIT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA STARTER KIT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE02) ozanimod (adm: O) | ZEPOSIA | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | Bristol-MyersSquibbCompany |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 12 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 12 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 0.25MG TAB | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 1MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AE03) siponimod (adm: O) | MAYZENT 1MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
Pages
